Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06248086
Title A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Site AU61008 RECRUITING Camperdown New South Wales 2050 Australia Details
Site AU61004 RECRUITING Fitzroy Victoria 3065 Australia Details
Site AU61005 RECRUITING Melbourne Victoria Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field